These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8230298)

  • 1. Rationale for selecting exfoliated bladder cell micronuclei as potential biomarkers for arsenic genotoxicity.
    Smith AH; Hopenhayn-Rich C; Warner M; Biggs ML; Moore L; Smith MT
    J Toxicol Environ Health; 1993; 40(2-3):223-34. PubMed ID: 8230298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water.
    Moore LE; Smith AH; Hopenhayn-Rich C; Biggs ML; Kalman DA; Smith MT
    Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):31-6. PubMed ID: 8993795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada.
    Warner ML; Moore LE; Smith MT; Kalman DA; Fanning E; Smith AH
    Cancer Epidemiol Biomarkers Prev; 1994; 3(7):583-90. PubMed ID: 7827589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of urinary arsenic to intake estimates and a biomarker of effect, bladder cell micronuclei.
    Biggs ML; Kalman DA; Moore LE; Hopenhayn-Rich C; Smith MT; Smith AH
    Mutat Res; 1997 Jun; 386(3):185-95. PubMed ID: 9219557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyses of micronuclei in exfoliated epithelial cells from individuals chronically exposed to arsenic via drinking water in inner Mongolia, China.
    Tian D; Ma H; Feng Z; Xia Y; Le XC; Ni Z; Allen J; Collins B; Schreinemachers D; Mumford JL
    J Toxicol Environ Health A; 2001 Nov; 64(6):473-84. PubMed ID: 11732698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.
    Tsuji JS; Alexander DD; Perez V; Mink PJ
    Toxicology; 2014 Mar; 317():17-30. PubMed ID: 24462659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water.
    Smith AH; Goycolea M; Haque R; Biggs ML
    Am J Epidemiol; 1998 Apr; 147(7):660-9. PubMed ID: 9554605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-control study of bladder cancer and arsenic in drinking water.
    Bates MN; Smith AH; Cantor KP
    Am J Epidemiol; 1995 Mar; 141(6):523-30. PubMed ID: 7900719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the fluorescent micronucleus assay to detect the genotoxic effects of radiation and arsenic exposure in exfoliated human epithelial cells.
    Moore LE; Warner ML; Smith AH; Kalman D; Smith MT
    Environ Mol Mutagen; 1996; 27(3):176-84. PubMed ID: 8625953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micronuclei as biomarkers of carcinogen exposure in populations exposed to arsenic through drinking water in West Bengal, India: a comparative study in three cell types.
    Basu A; Ghosh P; Das JK; Banerjee A; Ray K; Giri AK
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):820-7. PubMed ID: 15159315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data.
    Lynch HN; Zu K; Kennedy EM; Lam T; Liu X; Pizzurro DM; Loftus CT; Rhomberg LR
    Environ Int; 2017 Sep; 106():178-206. PubMed ID: 28625818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic and bladder cancer: observations and suggestions.
    Radosavljević V; Jakovljević B
    J Environ Health; 2008 Oct; 71(3):40-2. PubMed ID: 18990932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of cancer risk and environmental levels of arsenic in New Hampshire.
    Karagas MR; Stukel TA; Tosteson TD
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):85-94. PubMed ID: 12018020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic-related chromosomal alterations in bladder cancer.
    Moore LE; Smith AH; Eng C; Kalman D; DeVries S; Bhargava V; Chew K; Moore D; Ferreccio C; Rey OA; Waldman FM
    J Natl Cancer Inst; 2002 Nov; 94(22):1688-96. PubMed ID: 12441324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between arsenic concentrations in drinking water and lung and bladder cancer incidence in U.S. counties.
    Mendez WM; Eftim S; Cohen J; Warren I; Cowden J; Lee JS; Sams R
    J Expo Sci Environ Epidemiol; 2017 May; 27(3):235-243. PubMed ID: 27901016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinogen exposure and gene promoter hypermethylation in bladder cancer.
    Marsit CJ; Karagas MR; Danaee H; Liu M; Andrew A; Schned A; Nelson HH; Kelsey KT
    Carcinogenesis; 2006 Jan; 27(1):112-6. PubMed ID: 15987713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire.
    Karagas MR; Tosteson TD; Morris JS; Demidenko E; Mott LA; Heaney J; Schned A
    Cancer Causes Control; 2004 Jun; 15(5):465-72. PubMed ID: 15286466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential effect modifiers of the arsenic-bladder cancer risk relationship.
    Koutros S; Baris D; Waddell R; Beane Freeman LE; Colt JS; Schwenn M; Johnson A; Ward MH; Hosain GM; Moore LE; Stolzenberg-Solomon R; Rothman N; Karagas MR; Silverman DT
    Int J Cancer; 2018 Dec; 143(11):2640-2646. PubMed ID: 29981168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in bladder cell micronucleus prevalence after intervention to lower the concentration of arsenic in drinking water.
    Moore LE; Smith AH; Hopenhayn-Rich C; Biggs ML; Kalman DA; Smith MT
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1051-6. PubMed ID: 9419402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA.
    Meliker JR; Slotnick MJ; AvRuskin GA; Schottenfeld D; Jacquez GM; Wilson ML; Goovaerts P; Franzblau A; Nriagu JO
    Cancer Causes Control; 2010 May; 21(5):745-57. PubMed ID: 20084543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.